Therapeutic advances of rituximab alone or plus other drugs for membranous nephropathy
Membranous nephropathy (MN) is a common pathological type of adult nephrotic syndrome. According to the etiology, MN is divided into idiopathic membranous nephropathy (IMN) and secondary membranous nephropathy (SMN). IMN accounts for around 80% of MN patients. Glucocorticoid plus alkylating agents o...
Saved in:
Main Authors: | Chao Zhang (Author), Hui Liao (Author), Rong-shan Li (Author) |
---|---|
Format: | Book |
Published: |
Editorial Department of Journal of Clinical Nephrology,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research advances of factors and mechanisms for therapeutic efficacy of rituximab for primary membranous nephropathy
by: Yu-ting Liu, et al.
Published: (2024) -
Rituximab in patients with membranous nephropathy and kidney insufficiency
by: Yanhong Guo, et al.
Published: (2022) -
Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
by: Zhi-hui Tu, et al.
Published: (2024) -
Efficacy and safety of rituximab in elderly patients with membranous nephropathy
by: Yanhong Guo, et al.
Published: (2023) -
Two cases of idiopathic membranous nephropathy treated with rituximab
by: Jae Young Yoon, et al.
Published: (2013)